Neoplasia

Neoplasia

瘤形成

  • 2区 中科院分区
  • Q2 JCR分区

期刊简介

《Neoplasia》是由Neoplasia Press出版社于1999年创办的英文国际期刊(ISSN: 1476-5586,E-ISSN: 1476-5586),该期刊长期致力于肿瘤学领域的创新研究,主要研究方向为ONCOLOGY。作为SCI、SCIE收录期刊(JCR分区 Q2,中科院 2区),本刊采用OA开放获取模式(OA占比1%),以发表肿瘤学领域等方向的原创性研究为核心(研究类文章占比94.49%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在127篇,确保学术质量与前沿性。成果覆盖Web of ScienceWeb of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Neoplasia审稿周期约为12 Weeks。该刊近年未被列入国际预警名单,年发文量约127篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCI、SCIE 期刊收录
  • 127 发文量

中科院分区

《新锐期刊分区表》(2026年3月发布)

Top期刊 综述期刊 大类学科 小类学科
医学
2区
ONCOLOGY 肿瘤学
2区

期刊分区表(2025年3月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
2区
ONCOLOGY 肿瘤学
3区

期刊分区表(2023年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
2区
ONCOLOGY 肿瘤学
2区

期刊分区表(2022年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
2区
ONCOLOGY 肿瘤学
2区

期刊分区表(2021年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
2区
ONCOLOGY 肿瘤学
2区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q2 92 / 333

72.5

学科:ONCOLOGY SCIE Q1 47 / 333

86.04

2023-2024年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q1 48 / 322

85.2

学科:ONCOLOGY SCIE Q1 45 / 322

86.18

CiteScore(2026年6月最新版)

CiteScore SJR SNIP CiteScore 排名
CiteScore:11.4 SJR:2.284 SNIP:1.733
学科类别 分区 排名 百分位
大类:Biochemistry, Genetics and Molecular Biology 小类:Cancer Research Q1 39 / 233

83%

期刊发文

  • Assessing axitinib-induced differential responses in tumor vascularization and oxygenation with combined optoacoustic angiography and diffuse optical spectroscop

    Author: Orlova, Anna; Akhmedzhanova, Ksenia; Glyavina, Anna; Kurnikov, Alexey; Khochenkov, Dmitry; Khochenkova, Yulia; Korobov, Artemii; Volovetskiy, Artur; Yudintsev, Andrey; Nerush, Anastasiya; Maslennikova, Anna; Vodeneev, Vladimir; Turchin, Ilya; Liu, Wei; Razansky, Daniel; Subochev, Pavel

    Journal: NEOPLASIA. 2026; Vol. 76, Issue , pp. -. DOI: 10.1016/j.neo.2026.101303

  • BPGM as an intrinsic brake to constrain metastasis through phospho-epigenetic-mediated carnitine biosynthesis suppressio

    Author: Wu, Meng-Zhi; Feng, Dou; Liu, Wu-Ping; Huang, Wei-Lun; Wu, Qiang; Chou, Tian-Sheng; Xiao, Wen-Hao; Yao, Zhou-Zhou; Li, Zhen-Jiang; Xie, Ting-Ting; Chen, Chang-Han; Yang, Zhi-Yu; Mao, Rui-Wen; Wu, Ci-Chun; Wang, Jun-Cheng; Zhang, Yu-Jin; Kellems, Rodney E.; Xia, Yang

    Journal: NEOPLASIA. 2026; Vol. 75, Issue , pp. -. DOI: 10.1016/j.neo.2026.101299

  • PRAS40 activates the IRE1α-XBP-1-mediated unfolded protein response to exacerbate colorectal cancer by enhancing ST6Gal1-dependent α-2, 6 sialylation of GRP7

    Author: Teng, Hongming; Guo, Yuxin; Chen, Xinran; Fan, Anlian; Zhang, Chengfei; Zhang, Ting; Luo, Yuanyuan; Huang, Lin

    Journal: NEOPLASIA. 2026; Vol. 75, Issue , pp. -. DOI: 10.1016/j.neo.2026.101297

  • The Cyclin C-CDK8/19 Mediator kinase module controls PRCC-TFE3 driven senescence in renal epithelium and tumorigenesis in TFE3-RC

    Author: Kuroda, Shoichiro; Funasaki, Shintaro; Nishizawa, Hidekazu; Schmidt, Laura S.; Kurahashi, Ryoma; Ito, Takaaki; Arima, Yuichiro; Tanaka, Miwa; Kitada, Atsuya; James, Amy M.; Hasumi, Hisashi; Jikuya, Ryosuke; Makiyama, Kazuhide; Kurotaki, Daisuke; Minami, Takashi; Difilippantonio, Simone; Linehan, W. Marston; Oike, Yuichi; Sawa, Tomohiro; Tanaka, Yasuhito; Suda, Toshio; Yokokawa, Ryuji; Nakamura, Takuro; Baba, Masaya; Kamba, Tomomi

    Journal: NEOPLASIA. 2026; Vol. 75, Issue , pp. -. DOI: 10.1016/j.neo.2026.101296

  • ESM1 drives cancer angiogenesis and bevacizumab resistance via trioleate synthesi

    Author: Chen, Xun; Wan, Jian; Jiang, Zhengwu; Zhao, Zhijian; Tang, Caixi; Li, Yukun; Wang, Dong

    Journal: NEOPLASIA. 2026; Vol. 75, Issue , pp. -. DOI: 10.1016/j.neo.2026.101298

  • Mechanistic insights and therapeutic interventions of mitochondrial quality control in chemotherapy-related cognitive impairmen

    Author: Chen, Jie; Chu, Xinyu; Wu, Yue; Su, Li; Wang, Mingqi; Zhao, Xuemei; Wei, Xiaohong; Xia, Guiyang; Xia, Huan; Lin, Sheng; Zhang, Mei

    Journal: NEOPLASIA. 2026; Vol. 74, Issue , pp. -. DOI: 10.1016/j.neo.2026.101291

  • Microbial crosstalk along the oral-gut axis: organ-specific oncogenic adaptations of Porphyromonas gingivalis and Fusobacterium nucleatu

    Author: Wu, Shiwang; Ye, Xinyi; Wang, Jingsi; Li, Mei; Fu, Yage; Wang, Shan

    Journal: NEOPLASIA. 2026; Vol. 74, Issue , pp. -. DOI: 10.1016/j.neo.2026.101290

  • MYLK4 promotes colorectal cancer progression by regulating lipid metabolism reprogramming via targeting ferroptosi

    Author: Wang, Bishi; Wu, Kongxiu; Liu, Xin; Shen, Yuhai; Li, Yanliang

    Journal: NEOPLASIA. 2026; Vol. 73, Issue , pp. -. DOI: 10.1016/j.neo.2025.101270